Name: 글로벌 시장 동향
SKU: MD4259
Availability: InStock

보고서 요약(국문)

시장 개요
중재 심장학 및 말초혈관 기기는 카테터를 이용하여 최소 침습적으로 다양한 심혈관 질환을 치료하는 데 사용되는 기기입니다. 이러한 기기는 특히 심장 질환 관련 환자 치료에 사용됩니다.
시장 동향
말초혈관 기기 분야의 급속한 기술 발전이 시장 성장을 견인할 것으로 예상됩니다.
말초동맥질환(PAD)은 시간이 지남에 따라 관련 위험 요인 및 동반 질환의 유병률, 특히 인슐린 의존성 당뇨병의 증가와 흡연 양상의 변화에 따라 변화해 왔습니다. 특히 혈관내 치료법은 신기술의 발전과 함께 크게 성장했습니다. 혈관내 치료가 가능한 질환을 가진 환자에게는 다양한 치료 옵션이 있습니다. 예를 들어, 풍선 혈관성형술과 스텐트 삽입술은 혈관내 치료의 강력한 기반을 제공했으며, 죽상동맥절제술은 대퇴동맥이나 슬와동맥과 같이 일반적으로 스텐트 삽입이 어려운 해부학적 위치에서 추가적인 치료 옵션으로 개발되었습니다. 동맥경화제거술은 방향성, 회전성, 궤도형, 레이저 동맥경화제거술의 네 가지 주요 기능 방식을 통해 다양한 전문 분야에서 널리 사용되고 있습니다.
방향성 동맥경화제거술은 병변 유형에 따라 크기가 다른 탄화물 절삭날을 사용하여 맞춤형 시술을 가능하게 합니다. 원위부 보호 장치를 삽입한 후, 절삭날이 회전하면서 병변을 따라 이동합니다. 절삭날이 전진함에 따라 발생하는 입자들은 보호 장치에 의해 차단됩니다.
제한 요인:
저소득 국가에서는 고도의 전문 기술을 요하는 심장 중재 시술 및 말초 혈관 기기의 승인 절차가 매우 엄격합니다. 이러한 기기들은 인체에 삽입되는 특수 장비이기 때문입니다. 스텐트 가격은 기술 발전과 함께 상승하고 있습니다. 예를 들어, 생분해성 스텐트의 가격은 약물 방출 스텐트의 두 배에 달합니다. 약물 코팅 풍선 또한 다른 심장 중재 시술 및 말초 혈관 기기에 비해 가격이 높습니다. 또한, 병원 인프라 부족과 대체 치료법의 용이한 접근성은 심장 중재 시술 및 말초 혈관 기기 시장의 성장을 저해하는 요인으로 작용할 수 있습니다.

COVID-19 영향 분석
SARS-CoV-2 바이러스로 인한 전염병은 전 세계적인 봉쇄를 초래했으며, 심장 중재 시술 및 말초 혈관 기기 분야에 심각한 타격을 입혔습니다. 심장 질환, 특히 심근경색 위험이 있는 사람들은 바이러스 감염 위험이 높으며, 제때 진단받지 못할 경우 사망 확률이 매우 높습니다. 또한, 적시 진단 부족으로 인해 장기적으로 심혈관 건강이 악화될 수 있다는 심각한 우려가 제기되고 있습니다. 심혈관 질환 치료 및 치료제에 대한 환자 접근성을 보장하는 이해관계자가 매우 부족한 상황입니다. 더불어, 청진기와 같은 기기를 사용하여 COVID-19 확진 환자의 심장 소리(딸깍거리는 소리, 잡음, 마찰음 등)를 듣고 식별하는 과정에서 바이러스 감염 위험이 증가할 수 있습니다. 또한, 팬데믹으로 인해 의료 공급망이 차질을 빚고 있으며, 많은 기업들이 제품 공급을 유지하고 공급망을 보호하기 위해 향후 다른 지역으로 생산 기지를 이전할 것으로 예상됩니다. 하지만 이러한 상황은 예측 기간 내에 점차 개선될 것으로 전망됩니다.

세그먼트 분석
PTCA 풍선 부문은 중재 심장학 및 말초 혈관 기기 시장에서 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.
PTCA 풍선 부문은 2020년에 가장 큰 시장 점유율을 기록했습니다. 동맥 협착을 줄여 혈류를 개선하는 등 관상동맥 질환 치료에 있어 여러 장점이 있어 제품 선호도가 높습니다. 예를 들어, 경피적 관상동맥 중재술이라고도 하는 관상동맥 성형술은 막힌 심장 동맥을 열어주는 시술입니다. 성형술은 막힌 혈관에 작은 풍선 카테터를 삽입하여 혈관을 넓히고 심장으로 가는 혈류를 개선합니다. 성형술은 종종 스텐트라고 하는 작은 철망 튜브를 삽입하는 것과 병행됩니다. 스텐트는 동맥을 확장시켜 다시 좁아질 가능성을 줄여줍니다. 대부분의 스텐트는 동맥을 열린 상태로 유지하는 데 도움이 되는 약물이 코팅되어 있습니다(약물 방출 스텐트). 드물게 금속 스텐트가 사용되기도 합니다.

또한, 혈관성형술은 흉통과 호흡곤란과 같은 동맥 폐색 증상을 개선할 수 있습니다. 심근경색 시 막힌 동맥을 신속하게 확장하고 심장 손상을 줄이기 위해서도 자주 사용됩니다. 따라서 위와 같은 이유로 중재 심장학 및 말초혈관 기기에 대한 수요가 증가했습니다. 이에 따라 해당 부문은 예측 기간 동안 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.
판막성형술 부문은 중재 심장학 및 말초혈관 기기 시장에서 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.
판막성형술 부문은 2020년에도 가장 큰 시장 점유율을 기록했습니다. 미국 질병통제예방센터(CDC)에 따르면 인구의 약 13%가 판막 심장 질환을 앓고 있습니다. 판막성형술은 심각한 판막 협착, 특히 폐동맥판막과 승모판막 협착에 광범위하게 적용됩니다. 따라서 판막 질환의 증가와 함께 해당 부문은 예측 기간 동안 상당한 성장을 보일 것입니다.

지리적 분석
북미 지역은 전 세계 중재 심장학 및 말초 혈관 기기 시장에서 가장 큰 시장 점유율을 차지하고 있습니다.
2020년 북미는 가장 높은 매출 점유율을 기록했습니다. 당뇨병 유병률 증가, 고령화 인구 증가, 최소 침습 시술 개발, 시장 참여 업체들의 신제품 출시, 그리고 용이한 보험 적용 등이 향후 시장 성장을 견인할 것으로 예상됩니다. 예를 들어, 미국 질병통제예방센터(CDC)에 따르면 당뇨병으로 인한 사망률은 2019년과 2020년 사이에 약 14% 증가했습니다. 2019년 인구 10만 명당 21.6명이었던 당뇨병 사망률은 2020년 24.6명으로 상승했습니다. 당뇨병으로 인한 높은 혈당은 혈관과 심장 및 혈관을 조절하는 신경을 손상시킬 수 있으며, 시간이 지남에 따라 심장 질환으로 이어질 수 있습니다. 당뇨병 환자는 당뇨병이 없는 사람보다 더 젊은 나이에 심장 질환이 발병하는 경향이 있습니다.

또한, 바이오트로닉(Biotronik)은 2021년 9월 29일, 자사의 오르시로 미션(Orsiro® Mission) 생분해성 고분자 약물 방출 스텐트 시스템(BP-DES)이 미국 식품의약국(FDA)의 승인을 받았다고 발표했습니다. 따라서 위와 같은 발표로 인해 중재 심장학 및 말초 혈관 기기에 대한 수요가 증가했습니다. 이러한 요인들을 고려할 때, 북미 지역은 예측 기간 동안 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.
경쟁 환경
중재 심장학 및 말초 혈관 기기 시장의 주요 업체로는 텔레플렉스(Teleflex Incorporated), 인시투 테크놀로지스(InSitu Technologies), 코메드(Comed), 스펙트라네틱스(Spectranetics), 헥사카스(Hexacath), 레푸 메디컬 테크놀로지(Lepu Medical Technology), 선전 마이크로어프로치 메디컬 테크놀로지(Shenzhen MicroApproach Medical Technology), 메드트로닉(Medtronic Inc.) 등이 있습니다.
레푸 메디컬 테크놀로지(베이징) 유한회사(Lepu Medical Technology (Beijing) Co., Ltd.):
개요:
레푸 메디컬 테크놀로지(베이징) 유한회사는 1999년에 설립되었으며, 첨단 의료 기기 및 장비의 개발, 제조 및 유통을 전문으로 합니다. 레푸 메디컬(Lepu Medical)은 심혈관, 신경혈관 및 말초혈관 중재술, 구조적 심장 질환, 외과 심장학, 심장 리듬 관리, 마취 및 중환자 치료, 체외 진단 및 일반 외과 분야에서 세계적인 선도 기업으로 성장했습니다. 주요 제품으로는 관상동맥 스텐트, 확장 풍선 카테터, 중재 시술용 액세서리, 폐쇄 장치, 기계식 심장 판막, 전기생리학 카테터, 심박 조율기, 심장 체외 진단 제품, 마취 제품, 혈관 조영 시스템 및 수술용 스테이플러 등이 있습니다.
제품 포트폴리오:
슈퍼크로스™ PTA 풍선 확장 카테터: PTA 풍선 카테터는 말초 동맥 폐쇄 질환 환자의 경피적 혈관 성형술(PTA)에 사용됩니다.

보고서 요약(영어 원문)

Market Overview
Interventional cardiology and peripheral vascular devices are the types of devices that are used to treat different cardiovascular conditions with the help of catheters, with minimal invasion. These devices are specially used to treat patients related to heart problems.
Market Dynamics
Rapid technological advancements in peripheral vascular devices are expected to drive market growth.
Peripheral arterial disease (PAD) has changed over time as the prevalence of associated risk factors and co-morbidities—including the increase in insulin-dependent diabetes and the changing dynamic of tobacco use—has evolved. Endovascular therapies specifically have grown with the explosion of new technologies. There are numerous options for patients with disease amenable to endovascular therapy. For instance, balloon angioplasty and stenting have provided a strong base for endovascular therapy, and atherectomy developed as an additional option in anatomic locations not normally amenable to stents, including the common femoral artery or popliteal artery. Atherectomy has become widely adopted across specialities with four main function methods: directional, rotational, orbital, and laser atherectomy.
In contrast, directional atherectomy functions using a carbide cutting blade with varying sizes to customize the type of lesion. A distal protection device is placed, and then the blade rotates and is moved across the lesion. As the blade is advanced, the particles are contained by the protection device.
Restraint:
The approval processes in low-income countries are stringent for interventional cardiology & peripheral vascular devices, as these are highly specialized devices introduced in the body. The cost of stents increases with advancements in technology. For instance, the price of bioabsorbable stents is twice as much as the cost of drug-eluting stents. The cost of drug-coated balloons is also high compared to other interventional cardiology and peripheral vascular devices. Moreover, the lack of hospital infrastructure and easy availability of alternative treatments can challenge the interventional cardiology and peripheral vascular devices market.
COVID-19 Impact Analysis
The epidemic caused by the SARS-CoV-2 virus resulted in a global lockdown and wreaked havoc on interventional cardiology and peripheral vascular devices. There is an increased risk for people suffering from heart diseases to contract the virus, especially those prone to heart attacks, and there is a high probability of death if the virus is not diagnosed on time. Moreover, there are serious concerns about the long-term worsening of cardiovascular health outcomes due to a lack of timely diagnosis. There are very few multiple stakeholders for patient access to cardiovascular treatment and therapeutics. Also, the devices like stethoscopes may increase the risk of the virus when used to listen and identify specific heart sounds such as clicks, murmurs and rubs of the Covid-19 positive patient. Additionally, the pandemic is interrupting the medical supply chain, and many companies will vary to other geographic regions in the future to ensure that products remain available and protect their supply chain. However, the situation is expected to improve gradually in the forecast period.
Segment Analysis
PTCA Balloons segment is expected to hold the largest market share in the interventional cardiology and peripheral vascular devices market.
The PTCA balloons segment accounted for the largest market share in 2020. Its advantages in coronary atrial disease treatment, including reduced artery narrowing that improves the blood flow, lead to higher product preference. For instance, Coronary angioplasty, also called percutaneous coronary intervention, is a procedure used to open clogged heart arteries. Angioplasty uses a tiny balloon catheter inserted in a blocked blood vessel to help widen it and improve blood flow to the heart. Angioplasty is often combined with the placement of a small wire mesh tube called a stent. The stent helps prop the artery open, decreasing its chance of narrowing again. Most stents are coated with medication to help keep the artery open (drug-eluting stents). Rarely, bare-metal stents are used.
Moreover, angioplasty can improve symptoms of blocked arteries, such as chest pain and shortness of breath. It is also often used during a heart attack to quickly open a blocked artery and reduce the amount of damage to the heart. Therefore, the above statements have increased the demand for interventional cardiology and peripheral vascular devices. Thus, the segment is expected to hold the largest market share in the forecast period.
The valvuloplasty segment is expected to hold the largest market share in the interventional cardiology and peripheral vascular devices market.
The valvuloplasty segment accounted for the largest market share in 2020. According to the Centers for Disease Control and Prevention, approximately 13% of the population suffers from valvular heart disease. Valvuloplasty offers comprehensive applications in severe valve narrowing and narrowing of the pulmonary and mitral valves, among others. Therefore, with the rise in valvular diseases, the segment will observe substantial growth during the forecast timeline.
Geographical Analysis
North America region holds the largest market share in the global interventional cardiology and peripheral vascular devices market
In 2020, North America accounted for the highest revenue share. The increasing prevalence of diabetes, increase in the ageing population, development of minimally invasive procedures, product launches by the market players and easy availability of reimbursement are some factors that the market is expected to boost in the forecast period. For instance, according to the Centers for Disease Control and Prevention, The death rate for diabetes jumped nearly 14 per cent between 2019 and 2020. In 2019, the diabetes death rate was 21.6 per 100,000 populations, rising to 24.6 in 2020. Therefore, high blood glucose from diabetes can damage blood vessels and the nerves that control the heart and blood vessels. Over time, this damage can lead to heart disease. People with diabetes tend to develop heart disease at a younger age than people without diabetes.
Moreover, Biotronik, on September 29, 2021, announced it received U.S. Food and Drug Administration (FDA) approval for its Orsiro® Mission bioabsorbable polymer drug-eluting stent system (BP-DES). Hence, the above statements have increased the demand for interventional cardiology and peripheral vascular devices. Thus, the North American region is expected to hold the largest market share in the forecast period from the above statements.
Competitive Landscape
Major key players in the interventional cardiology and peripheral vascular devices market are Teleflex Incorporated, InSitu Technologies, Comed, Spectranetics, Hexacath, Lepu Medical Technology, Shenzhen MicroApproach Medical Technology and Medtronic Inc.
Lepu Medical Technology (Beijing) Co., Ltd.:
Overview:
Lepu Medical Technology (Beijing) Co., Ltd. was established in 1999. It is specialized in developing, manufacturing and distributing high-tech medical devices and equipment. Lepu Medical has grown into a global leading group company in the fields of cardiovascular, neurovascular and peripheral vascular interventions, structural heart diseases, surgical cardiology, cardiac rhythm management, anesthesia and intensive care, in vitro diagnostics and general surgery with products include coronary stents, dilatation balloon catheters, interventional accessories, occlusion devices, mechanical heart valves, electrophysiology catheters, pacemakers, cardiac in vitro diagnosis products, anesthetic products, angiography systems and surgical staplers.
Product Portfolio:
Supercross™ PTA Balloon Dilatation Catheters: PTA balloon catheter is indicated for percutaneous transluminal angioplasty (PTA) in patients with obstructive disease of peripheral arteries.

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
3.1. Market Snippet by Product type
3.2. Market Snippet by Application
3.3. Market Snippet by End user
3.4. Market Snippet by Region
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Rapid technological advancements in peripheral vascular devices are expected to drive market growth.
4.1.2. Restraints
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Unmet Needs
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
6.7. Others
7. By Product type
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
7.1.2. Market Attractiveness Index, By Product Type Segment
7.2. Interventional Catheters*
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
7.3. Guidewires
7.4. Stents
7.5. PTCA Balloons
7.6. Atherectomy Devices
7.7. Chronic Total Occlusion Devices
7.8. Synthetic Surgical Grafts
7.9. Embolic Protection Devices
7.10. IVC filters
7.11. Others
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application Segment
8.2. Congenital Heart Defect Correction*
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
8.3. Coronary Thrombectomy
8.4. Angioplasty
8.5. Valvuloplasty
8.6. Percutaneous Valve Repair
8.7. Others
9. By End-user
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
9.1.2. Market Attractiveness Index, By End user Segment
9.2. Hospitals*
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
9.3. Ambulatory Surgical Centers
9.4. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. U.K.
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
11. Competitive Landscape
11.1. Key Developments and Strategies
11.2. Company Share Analysis
11.3. Product Benchmarking
11.4. List of Key Companies to Watch
11.5. List of Company with disruptive technology
12. Company Profiles
12.1. Lepu Medical Technology*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Key Highlights
12.1.4. Financial Overview
12.2. InSitu Technologies
12.3. Comed
12.4. Spectranetics
12.5. Hexacath
12.6. Medtronic Inc.
12.7. Shenzhen MicroApproach Medical Technology
12.8. Teleflex Incorporated(*LIST NOT EXHAUSTIVE)
13. DataM Intelligence
13.1. Appendix
13.2. About Us
13.3. Contact Us

언급된 주요 기업들

Lepu Medical Technology, InSitu Technologies, Comed, Spectranetics, Hexacath, Medtronic Inc., Shenzhen MicroApproach Medical Technology

표 목록 (Tables)

List of Tables Table 1 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)

Table 2 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)

Table 3 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)

Table 4 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)

Table 5 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)

Table 6 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 7 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)

Table 8 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By Application, 2022-2033 (US$ Billion)

Table 9 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)

Table 10 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By End-User, 2022-2033 (US$ Billion)

Table 11 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)

Table 12 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By Region, 2022-2033 (US$ Billion)

Table 13 North America Interventional Cardiology and Peripheral Vascular Devices Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 14 North America Interventional Cardiology and Peripheral Vascular Devices Market Value, By Application, 2022-2033 (US$ Billion)

Table 15 North America Interventional Cardiology and Peripheral Vascular Devices Market Value, By End-User, 2022-2033 (US$ Billion)

Table 16 North America Interventional Cardiology and Peripheral Vascular Devices Market Value, By Country, 2022-2033 (US$ Billion)

Table 17 Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 18 Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market Value, By Application, 2022-2033 (US$ Billion)

Table 19 Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market Value, By End-User, 2022-2033 (US$ Billion)

Table 20 Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market Value, By Country, 2022-2033 (US$ Billion)

Table 21 Europe Interventional Cardiology and Peripheral Vascular Devices Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 22 Europe Interventional Cardiology and Peripheral Vascular Devices Market Value, By Application, 2022-2033 (US$ Billion)

Table 23 Europe Interventional Cardiology and Peripheral Vascular Devices Market Value, By End-User, 2022-2033 (US$ Billion)

Table 24 Europe Interventional Cardiology and Peripheral Vascular Devices Market Value, By Country, 2022-2033 (US$ Billion)

Table 25 South America Interventional Cardiology and Peripheral Vascular Devices Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 26 South America Interventional Cardiology and Peripheral Vascular Devices Market Value, By Application, 2022-2033 (US$ Billion)

Table 27 South America Interventional Cardiology and Peripheral Vascular Devices Market Value, By End-User, 2022-2033 (US$ Billion)

Table 28 South America Interventional Cardiology and Peripheral Vascular Devices Market Value, By Country, 2022-2033 (US$ Billion)

Table 29 Middle East and Africa Interventional Cardiology and Peripheral Vascular Devices Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 30 Middle East and Africa Interventional Cardiology and Peripheral Vascular Devices Market Value, By Application, 2022-2033 (US$ Billion)

Table 31 Middle East and Africa Interventional Cardiology and Peripheral Vascular Devices Market Value, By End-User, 2022-2033 (US$ Billion)

Table 32 Middle East and Africa Interventional Cardiology and Peripheral Vascular Devices Market Value, By Country, 2022-2033 (US$ Billion)

Table 33 B. Braun Interventional Systems Inc.: Overview

Table 34 B. Braun Interventional Systems Inc.: Product Portfolio

Table 35 B. Braun Interventional Systems Inc.: Key Developments

Table 36 Boston Scientific Corporation: Overview

Table 37 Boston Scientific Corporation: Product Portfolio

Table 38 Boston Scientific Corporation: Key Developments

Table 39 BD: Overview

Table 40 BD: Product Portfolio

Table 41 BD: Key Developments

Table 42 Medtronic: Overview

Table 43 Medtronic: Product Portfolio

Table 44 Medtronic: Key Developments

Table 45 Teleflex Incorporated: Overview

Table 46 Teleflex Incorporated: Product Portfolio

Table 47 Teleflex Incorporated: Key Developments

Table 48 Lepu Medical Technology (Beijing)Co., Ltd: Overview

Table 49 Lepu Medical Technology (Beijing)Co., Ltd: Product Portfolio

Table 50 Lepu Medical Technology (Beijing)Co., Ltd: Key Developments

Table 51 TERUMO CORPORATION: Overview

Table 52 TERUMO CORPORATION: Product Portfolio

Table 53 TERUMO CORPORATION: Key Developments

Table 54 Cook: Overview

Table 55 Cook: Product Portfolio

Table 56 Cook: Key Developments

Table 57 Shenzhen MicroApproach Medical Technology Co., Ltd: Overview

Table 58 Shenzhen MicroApproach Medical Technology Co., Ltd: Product Portfolio

Table 59 Shenzhen MicroApproach Medical Technology Co., Ltd: Key Developments

Table 60 Biotronik: Overview

Table 61 Biotronik: Product Portfolio

Table 62 Biotronik: Key Developments

그림 목록 (Figures)

List of Figures Figure 1 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)

Figure 2 Global Interventional Cardiology and Peripheral Vascular Devices Market Share, By Product Type, 2024 & 2033 (%)

Figure 3 Global Interventional Cardiology and Peripheral Vascular Devices Market Share, By Application, 2024 & 2033 (%)

Figure 4 Global Interventional Cardiology and Peripheral Vascular Devices Market Share, By End-User, 2024 & 2033 (%)

Figure 5 Global Interventional Cardiology and Peripheral Vascular Devices Market Share, By Region, 2024 & 2033 (%)

Figure 6 Global Interventional Cardiology and Peripheral Vascular Devices Market Y-o-Y Growth, By Product Type, 2023-2033 (%)

Figure 7 Interventional Catheters Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)

Figure 8 Guidewires Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)

Figure 9 Stents Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)

Figure 10 Atherectomy Devices Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)

Figure 11 PTCA Balloons Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)

Figure 12 Chronic Total Occlusion Devices Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)

Figure 13 Synthetic Surgical Grafts Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)

Figure 14 Embolic Protection Devices Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)

Figure 15 Others Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)

Figure 16 Global Interventional Cardiology and Peripheral Vascular Devices Market Y-o-Y Growth, By Application, 2023-2033 (%)

Figure 17 Angioplasty Application in Global Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)

Figure 18 Coronary Thrombectomy Application in Global Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)

Figure 19 Congenital Heart Defect Correction Application in Global Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)

Figure 20 Valvuloplasty Application in Global Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)

Figure 21 Percutaneous Valve Repair Application in Global Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)

Figure 22 Others Application in Global Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)

Figure 23 Global Interventional Cardiology and Peripheral Vascular Devices Market Y-o-Y Growth, By End-User, 2023-2033 (%)

Figure 24 Hospitals End-User in Global Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)

Figure 25 Ambulatory Surgical Centers End-User in Global Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)

Figure 26 Others End-User in Global Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)

Figure 27 Global Interventional Cardiology and Peripheral Vascular Devices Market Y-o-Y Growth, By Region, 2023-2033 (%)

Figure 28 North America Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)

Figure 29 North America Interventional Cardiology and Peripheral Vascular Devices Market Share, By Product Type, 2024 & 2033 (%)

Figure 30 North America Interventional Cardiology and Peripheral Vascular Devices Market Share, By Application, 2024 & 2033 (%)

Figure 31 North America Interventional Cardiology and Peripheral Vascular Devices Market Share, By End-User, 2024 & 2033 (%)

Figure 32 North America Interventional Cardiology and Peripheral Vascular Devices Market Share, By Country, 2024 & 2033 (%)

Figure 33 Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)

Figure 34 Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market Share, By Product Type, 2024 & 2033 (%)

Figure 35 Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market Share, By Application, 2024 & 2033 (%)

Figure 36 Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market Share, By End-User, 2024 & 2033 (%)

Figure 37 Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market Share, By Country, 2024 & 2033 (%)

Figure 38 Europe Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)

Figure 39 Europe Interventional Cardiology and Peripheral Vascular Devices Market Share, By Product Type, 2024 & 2033 (%)

Figure 40 Europe Interventional Cardiology and Peripheral Vascular Devices Market Share, By Application, 2024 & 2033 (%)

Figure 41 Europe Interventional Cardiology and Peripheral Vascular Devices Market Share, By End-User, 2024 & 2033 (%)

Figure 42 Europe Interventional Cardiology and Peripheral Vascular Devices Market Share, By Country, 2024 & 2033 (%)

Figure 43 South America Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)

Figure 44 South America Interventional Cardiology and Peripheral Vascular Devices Market Share, By Product Type, 2024 & 2033 (%)

Figure 45 South America Interventional Cardiology and Peripheral Vascular Devices Market Share, By Application, 2024 & 2033 (%)

Figure 46 South America Interventional Cardiology and Peripheral Vascular Devices Market Share, By End-User, 2024 & 2033 (%)

Figure 47 South America Interventional Cardiology and Peripheral Vascular Devices Market Share, By Country, 2024 & 2033 (%)

Figure 48 Middle East and Africa Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)

Figure 49 Middle East and Africa Interventional Cardiology and Peripheral Vascular Devices Market Share, By Product Type, 2024 & 2033 (%)

Figure 50 Middle East and Africa Interventional Cardiology and Peripheral Vascular Devices Market Share, By Application, 2024 & 2033 (%)

Figure 51 Middle East and Africa Interventional Cardiology and Peripheral Vascular Devices Market Share, By End-User, 2024 & 2033 (%)

Figure 52 B. Braun Interventional Systems Inc.: Financials

Figure 53 Boston Scientific Corporation: Financials

Figure 54 BD: Financials

Figure 55 Medtronic: Financials

Figure 56 Teleflex Incorporated: Financials

Figure 57 Lepu Medical Technology(Beijing)Co., Ltd: Financials

Figure 58 TERUMO CORPORATION: Financials

Figure 59 Cook: Financials

Figure 60 Shenzhen MicroApproach Medical Technology Co., Ltd: Financials

Figure 61 Biotronik: Financials